Company Search:
Advanced Search
Sponsored Links
Sonoma Pharmaceuticals Inc Company Snapshot
Sonoma Pharmaceuticals Inc operates within the Surgical and medical instruments sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sonoma Pharmaceuticals Inc with three other companies in this sector in the United States: Pro-Dex, Inc. (2019 sales of $27.17 million of which 90% was Medical devices), Beyond Air Inc ($7.72 million of which 100% was Contracts with Customers), and Encision Inc. ($8.80 million ).

Sales Analysis. During the year ended March of 2019, sales at Sonoma Pharmaceuticals Inc were $18.97 million. This is an increase of 13.9% versus 2018, when the company's sales were $16.66 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sonoma Pharmaceuticals Inc
  Stock Performance Chart for Sonoma Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 5.80
(Figures in U.S. Dollars)
1 Week -5.2%   13 Weeks 16.0%  
4 Weeks 3.4%   52 Weeks -44.4%  
Sonoma Pharmaceuticals Inc Key Data:
  Ticker: SNOA Country: United States
  Exchanges: NAS Major Industry: Health Care Equipment & Services
    Sub Industry: Surgical & Medical Instruments
  2019 Sales 18,970,000
(Year Ending Jan 2020).
Employees: 63
  Currency: U.S. Dollars Market Cap: 7,712,411
  Fiscal Yr Ends: March Shares Outstanding: 1,329,726
  Share Type: Common Closely Held Shares: 90,509
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.